Cumulative evidence has shown that the activation of the PI3K/mTOR signaling pathway plays an important role in the occurrence of malignant tumors; hence targeting suppression of this signaling pathway might be a promising therapeutic strategy for cancer treatment [46,47,48]. The gene discussed is MTOR; the disease is cancer.